Company news
Labcorp Holdings Inc. (NYSE:LH) news
Labcorp Holdings Inc. news releases on 6ix. Latest, Sep 30, 2026: Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
Press releases & updates
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
September 30, 2026
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
September 10, 2026
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
September 8, 2026
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
August 31, 2026
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
August 28, 2026
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
August 24, 2026
Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health
August 18, 2026
Labcorp to Host Investor Day on September 10, 2026
August 17, 2026
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
August 10, 2026
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
August 4, 2026
Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance
July 30, 2026
Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing
July 27, 2026
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026
June 30, 2026
Labcorp Announces Nationwide Availability of ColoSense(R), the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
June 23, 2026
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test
June 22, 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
May 29, 2026
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
May 28, 2026
Labcorp to Present at the Jefferies Global Healthcare Conference
May 27, 2026
Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time
May 20, 2026
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
May 12, 2026
Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance
April 30, 2026
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
April 24, 2026
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®
April 22, 2026
Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026
April 17, 2026
Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes
April 15, 2026
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
April 14, 2026
Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide
April 13, 2026
Labcorp to Announce First Quarter Financial Results on April 30, 2026
March 31, 2026
Labcorp Completes Acquisition of Select Assets of Crouse Health's Laboratory Alliance of Central New York's Laboratory Business, Enters Agreement to Manage Crouse's Inpatient Laboratory
March 20, 2026
Labcorp : Completes Acquisition of Select Assets of Crouse Health’s Laboratory Alliance of Central New York’s Laboratory Business; Enters Agreement to Manage Crouse’s Inpatient Laboratory
March 19, 2026
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
March 18, 2026
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
February 23, 2026
Labcorp Announces 2025 Fourth Quarter and Full Year Results
February 17, 2026
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care
February 11, 2026
Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors
February 9, 2026
MASHNET Announces Founding of MASLD Diagnostic Coalition
February 3, 2026
Death Clock Launches "Life Lab": An AI Health Concierge Democratizing Private-Doctor Level Care for the Mass Market
February 2, 2026
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
January 15, 2026
Labcorp Declares Quarterly Dividend
January 14, 2026
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
January 13, 2026
Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
January 8, 2026
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
January 8, 2026
PracticeQ Partners With Fullscript to Streamline Lab Testing and Improve Patient Care
January 6, 2026
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks
December 15, 2025
Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp
December 2, 2025
Labcorp Appoints Victor Bulto to Board of Directors
November 24, 2025
/C O R R E C T I O N -- Lunit/
November 20, 2025
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
November 19, 2025
KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle
November 3, 2025